Acknowledgments
HD, Saidykhan
We thank all workers at the MRC Unit The Gambia at London School of Hygiene & Tropical Medicine involved in the study for their help, in particular: Kabiru Ceesay, Mohammed Ngum, Edrisa Sinjanka, Patrick Nshe, Alasana Saidykhan, and Musa Jarjou, as well as the whole field team. We also thank the local health authorities, staff at the health facilities, and the communities of Kiang and Jarra. The authors acknowledge the data and safety monitoring board under the lead of Jay Berkley and the trial steering committee for their review of the study protocol and expert advice throughout the study. Finally, we are grateful to the many study participants and their families who were so willing to contribute to this study. This study was supported by the Hepcidin and Iron in Global Health Consortium, which was funded by the Bill & Melinda Gates Foundation (OPP1055865, awarded to the MRC Unit The Gambia at London School of Hygiene & Tropical Medicine). The MRC Unit The Gambia at London School of Hygiene & Tropical Medicine is supported by core funding (MC-A760–5QX00) by the UK MRC and the UK Department for International Development (DFID) under the Concordat agreement between the MRC and the UK DFID. RW, AMP, AB, LK, MMG, CC, SS, ED, EAS, AJ, MW, and JHC were funded through this arrangement. HD, S-RP, and AEA were funded by the MRC (MC_UU_12010/1), and HD was also funded by the UK National Institute for Health Research Biomedical Research Centre in Oxford. We sincerely thank DSM Nutritional Products (Johannesburg, South Africa) for the production and supply of the intervention products.